usfda


Pharma Firm Ipca Labs' Plant Gets 3 Observations From US Drugs Regulator

Banking - Published date: .

The observations were followed by the USFDA inspection at the site from April 18 to April 26 Read more

Zydus Lifesciences Gets Nod From USFDA For Metronidazole Topical Cream

Banking - Published date: .

The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad Read more

Booster Dose: Zydus Likely To Arm India With Single-dose Malaria Drug

Banking - Published date: .

In Phase-2 trials now, pill also works against drug-resistant malaria strains Read more

Global Pharma Recalls 50,000 Tubes Of Contaminated Eye Drops In US: USFDA

Banking - Published date: .

Global Pharma Healthcare is recalling 50,000 tubes of eye drops in the US market due to bacterial contamination, accordi... Read more

Glenmark Gets USFDA Nod For Generic Drug With 180-day Exclusivity

Banking - Published date: .

Glenmark Pharmaceuticals on Thursday said it has received an approval from the US health regulator to market a generic m... Read more

Glenmark Gets USFDA Nod To Market Generic Medication To Treat Schizophrenia

Banking - Published date: .

Glenmark Pharmaceuticals on Monday said it has received approval from the US health regulator to market a generic produc... Read more

USFDA Issues Form-483 With 1 Observation To Torrent Pharma

World - Published date: .

USFDA conducted the pre-approval inspection of the Torrent Pharma Bileshwarpura-based plant from March 13-March 17. Read more

Marksans Pharma Gets USFDA Nod For Generic Version Of Famotidine Tablets

Banking - Published date: .

Marksans Pharma Ltd on Friday said it has received final approval from the US health regulator for its generic version o... Read more

USFDA Issues 8 Observations For Cipla's Pithampur Manufacturing Facility

World - Published date: .

USFDA conducted a Good Manufacturing Practices (cGMP) inspection at Cipla's Pithampur manufacturing facility from 6-17 F... Read more

Sun Pharma Gets US Health Regulator Nod To Market Generic Medication

Banking - Published date: .

Sun Pharmaceutical Industries on Friday said its subsidiary has received approval from the US health regulator to market... Read more

Alkem Launches Novel Antibiotic Combination For Drug-resistant Infections

Banking - Published date: .

The formulation, to be sold under the Zidavi brans for Rs 2,700 a vial, has been approved by US FDA, European Medicines ... Read more

USFDA Issues Warning Letter To Lupin For Maharashtra-based API Plant

Banking - Published date: .

The US health regulator has pulled up drug maker Lupin for manufacturing lapses, including failure to establish adequate... Read more

Glenmark Pharma Gets US Health Regulator Nod For Generic Medication

Banking - Published date: .

Glenmark Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market Sodium Phenyl... Read more

USFDA Issues Import Alert On Glenmark Pharma's Baddi Manufacturing Plant

Banking - Published date: .

Glenmark Pharmaceuticals on Wednesday said the US health regulator has put its manufacturing plant at Baddi under import... Read more

Alembic Pharma Gets USFDA Approval To Market Pirfenidone Tablets

Banking - Published date: .

Alembic Pharmaceuticals said it has received approval from the US health regulator to market Pirfenidone tablets used to... Read more

Sun Pharma's Halol Unit Gets 10 Observations Under USFDA's Form 483

Banking - Published date: .

Plant's OAI status is unchanged, hinting at status quo; Sun Pharma says will respond to observations within 15 days Read more

Lupin's Goa Plant Gets 7 Observations From USFDA, Firm Unperturbed

Banking - Published date: .

Says confident of resolving matter, does not share nature of observations Read more

Zydus Cadila Gets USFDA Nod To Market Depression Treatment Drug In US

Banking - Published date: .

Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Vortioxetine Tab... Read more

Zydus Cadila Gets USFDA Nod For Arthritis Drug With 180-days Exclusivity

Banking - Published date: .

Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Tofacitinib extended-r... Read more

Zydus Cadila Gets USFDA Final Nod For Low Blood Pressure Drug Droxidopa

Banking - Published date: .

The newly approved medication will be manufactured at the group''s formulation manufacturing facility at SEZ, Ahmedabad Read more